Trial Profile
Same Lipid Lowering by Atorvastatin Versus Atorvastatin Plus Ezetimibe on Coronary Plaque Regression
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin
- Indications Atherosclerosis; Coronary artery disease
- Focus Therapeutic Use
- Acronyms SLLAECPR
- 17 Mar 2010 New trial record